Mosaic ImmunoEngineering (CPMV) Amortizatization of Intangibles (2022 - 2024)
Mosaic ImmunoEngineering (CPMV) posted quarterly Amortizatization of Intangibles of $1446.0 for Q1 2024, down 83.18% year-over-year from $8596.0 in Q2 2023, and down 1.09% quarter-over-quarter from $1462.0 in Q4 2023.
Mosaic ImmunoEngineering (CPMV) Amortizatization of Intangibles (2022 - 2024) Analysis & Trends
Mosaic ImmunoEngineering's Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $1446.0 for Q1 2024.
- In Q1 2024, Amortizatization of Intangibles fell 83.18% year-over-year to $1446.0; the TTM figure through Dec 2024 stood at $1446.0 (down 90.87% YoY), while the FY2024 annual figure was $1446.0, down 90.87% from the prior year.
- Amortizatization of Intangibles for Q1 2024 stood at $1446.0, down from $1462.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $26031.0 in Q2 2022, with the low at $1446.0 in Q1 2024.
- The 3-year median for Amortizatization of Intangibles is $8596.0 (2023), against an average of $11014.6.
- Peak annual rise in Amortizatization of Intangibles reached 58.0% in 2023, while the deepest fall reached 91.73% in 2023.
- Mosaic ImmunoEngineering's Amortizatization of Intangibles stood at $17672.0 in 2022, then plunged by 91.73% to $1462.0 in 2023, then slipped by 1.09% to $1446.0 in 2024.
- Business Quant data shows CPMV's Amortizatization of Intangibles at $1446.0 in Q1 2024, $1462.0 in Q4 2023, and $2907.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1,446.00 |
| Mar 31, 2024 | 1,446.00 |
| Dec 31, 2023 | 1,462.00 |
| Dec 31, 2023 | 1,462.00 |
| Sep 30, 2023 | 2,907.00 |
| Sep 30, 2023 | 2,907.00 |
| Jun 30, 2023 | 2,877.00 |
| Jun 30, 2023 | 2,877.00 |
| Mar 31, 2023 | 8,596.00 |
| Mar 31, 2023 | 8,596.00 |
| Dec 31, 2022 | 17,672.00 |
| Dec 31, 2022 | 17,672.00 |
| Sep 30, 2022 | 17,673.00 |
| Sep 30, 2022 | 17,673.00 |
| Jun 30, 2022 | 26,031.00 |
| Jun 30, 2022 | 26,031.00 |
| Mar 31, 2022 | 20,467.00 |
| Mar 31, 2022 | 20,467.00 |